Phibro Animal Health Corporation (PAHC) Return on equity 2017–2026
Phibro Animal Health Corporation (PAHC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
25.9%FY2026 · since FY2017: 42.7% → 25.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 25.9% | +9.0 pp |
| FY2025 | 16.9% | +16.0 pp |
| FY2024 | 0.9% | -10.6 pp |
| FY2023 | 11.5% | -7.2 pp |
| FY2022 | 18.7% | -4.1 pp |
| FY2021 | 22.8% | +5.0 pp |
| FY2020 | 17.8% | -7.5 pp |
| FY2019 | 25.3% | -9.8 pp |
| FY2018 | 35.1% | -7.7 pp |
| FY2017 | 42.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PAHC financial trends
PAHC RevenuePAHC Net incomePAHC Net marginPAHC Gross profitPAHC Gross marginPAHC Operating incomePAHC Operating marginPAHC Operating cash flowPAHC Free cash flowPAHC Capital expendituresPAHC Stock buybacksPAHC Dividends paidPAHC Total assetsPAHC Total liabilitiesPAHC Shareholders’ equityPAHC overview →